About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
PEER COMPARISON
Peer
Comparison
Lyka Labs Ltd.
Peer Companies
Price(Rs)
Chg(Rs)
Chg(%)
EPS(Rs.)
TTM P/E
Volume(000's)
1Year Return(%)
Divinded Yield
Book Value
Neuland Laboratories
17456.55
232.1
1.35
186.51
93.59
3978
12.28
0.07
1182.3
Ipca Laboratories
1494.5
191.8
14.72
30.32
49.29
177936
-2.76
0.27
271.64
Fredun Pharma
1788
85.1
5
61.21
29.21
15311
163.74
0.04
299.47
Procter&Gamble Healt
5886.95
80.35
1.38
184.83
31.85
260
14.44
2.12
320.52
Haleos Labs
1302
44.9
3.57
62.97
20.68
403
18.4
0.12
652.19
Concord Biotech
1499.2
44.7
3.07
30.73
48.79
5614
-20.81
0.71
173.27
Eris Lifesciences
1550.1
33.65
2.22
20.69
74.92
3199
14.5
0.47
183.9
Acutaas Chemicals
1712.4
29.9
1.78
27.57
62.12
13762
69.48
0.04
160.19
Pfizer
5072
24.75
0.49
183.46
27.65
1840
-2.68
3.25
921.84
Innova Captab
751.65
21.7
2.97
13.31
56.48
734
-24.19
0
142.06
Glenmark Pharma
1897.5
21.1
1.12
5.41
350.9
39916
23.88
0.13
868.26
Sun Pharma Inds.
1756.4
20.6
1.19
18.75
93.66
20035
-0.69
0.91
101.45
Everest Organics
427.95
20.1
4.93
6.38
67.05
13352
266.08
0
71
Lincoln Pharma
525.15
20
3.96
43.11
12.18
2484
-14.52
0.34
335.34
Shree Ganesh Remed.
473.25
16
3.5
15.92
29.73
3598
-33.43
0
113.1
Torrent Pharma
3839.7
14.3
0.37
62.26
61.68
5124
23.77
0.83
224.32
Aurobindo Pharma
1221.9
13.05
1.08
34.79
35.12
49980
-2.11
0
353.55
Auro Laboratories
230.3
10.9
4.97
1.12
205.05
23052
15.73
0
68.94
Mankind Pharma
2266.9
10.85
0.48
40.47
56.01
4918
-13.01
0
353.77
Dr. Reddy's Lab
1244.95
10.4
0.84
64.68
19.25
22038
1.54
0.64
344.27
Page
1
of
10
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.